Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Depreciation & Amortization (CF): 2020-2024

Historic Depreciation & Amortization (CF) for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $6.3 million.

  • Oncology Institute's Depreciation & Amortization (CF) rose 953.59% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 1400.03%. This contributed to the annual value of $6.3 million for FY2024, which is 704.92% up from last year.
  • Oncology Institute's Depreciation & Amortization (CF) amounted to $6.3 million in FY2024, which was up 704.92% from $5.9 million recorded in FY2023.
  • In the past 5 years, Oncology Institute's Depreciation & Amortization (CF) registered a high of $6.3 million during FY2024, and its lowest value of $3.2 million during FY2020.
  • Its 5-year average for Depreciation & Amortization (CF) is $4.6 million, with a median of $4.4 million in 2022.
  • In the last 5 years, Oncology Institute's Depreciation & Amortization (CF) skyrocketed by 512.9% in 2021 and then skyrocketed by 3314.44% in 2023.
  • Oncology Institute's Depreciation & Amortization (CF) (Annual) stood at $3.2 million in 2020, then rose by 5.13% to $3.3 million in 2021, then surged by 32.03% to $4.4 million in 2022, then soared by 33.14% to $5.9 million in 2023, then grew by 7.05% to $6.3 million in 2024.
  • Its Depreciation & Amortization (CF) stands at $6.3 million for FY2024, versus $5.9 million for FY2023 and $4.4 million for FY2022.